November 17, 2008 — Editor's note: Chronic kidney disease (CKD) in the elderly is highly prevalent and frequently overlaps with congestive heart failure and diabetes, posing unique challenges for the ...
The full guideline included 28 recommendations for which there is the greatest evidence and 141 practice points, which reflect the expert opinion of the group. HealthDay News — In a 2024 clinical ...
Conservative management of people with kidney failure throughout the chronic kidney disease (CKD) trajectory is discussed in ...
Cystatin C is emphasized as a preferred biomarker for accurate GFR measurement in CKD assessment. SGLT2i are recommended for CKD patients, regardless of diabetes status, for kidney and cardiovascular ...
An arsenal of highly effective medications now represent pillars in the prevention of chronic kidney disease (CKD) progression, yet with the drugs under-utilized among patients who need them the most, ...
Efficient clinical management of chronic kidney disease (CKD) is crucial for public health, as it is a progressive condition that affects 10% of the global population. Early diagnosis and active ...
CKD, a common, costly comorbidity in diabetes and heart failure, is currently managed in a suboptimal manner, as providers lack tools to accurately predict which patients will progress to renal ...
Chronic kidney disease isn’t fully reversible, but early diagnosis, medical care, and lifestyle changes can slow progression, ...
Each month, Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Each year there are 3.9 ...
Chronic kidney disease (CKD) is a public health challenge that affects more than 800 million people worldwide. 1 CKD can be caused by a variety of disease processes. Many causes are difficult to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results